A critical overview of concurrent chemoradiotherapy in cervical cancer

Current Oncology Reports

Volumn 6, Issue 6, 2004, Pages 463-470

  Sardi, Juan E ^a   Boixadera, María A ^a   Sardi, Juan J ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOGEN; CARBOXYHEMOGLOBIN; CISPLATIN; FLUOROURACIL; HEMOGLOBIN; HYDROXYUREA; OXYGEN; PERFLUORO COMPOUND; RECOMBINANT ERYTHROPOIETIN;

ANEMIA; BONE MARROW SUPPRESSION; CANCER CENTER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL PROTOCOL; CLINICAL STUDY; CLINICAL TRIAL; CONTROL GROUP; DATA ANALYSIS; DEVELOPING COUNTRY; DISEASE ASSOCIATION; HEALTH CARE COST; HUMAN; HYPOXIA; HYSTERECTOMY; PATIENT CARE; PATIENT COMPLIANCE; PROGNOSIS; PROSPECTIVE STUDY; PUBLICATION; QUALITATIVE ANALYSIS; RANDOMIZATION; RESOURCE ALLOCATION; REVIEW; STANDARDIZATION; UNITED STATES; UTERINE CERVIX CANCER;

EID: 9744260348     PISSN: 15233790     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11912-004-0077-3     Document Type: Review

References (33)

1. Parkin DM, Pisani P, Ferlay J: Global cancer statistics. CA Cancer J Clin 1999, 49:39-64.
2. The 1988 Bethesda System for reporting cervical/vaginal cytological diagnoses. National Cancer Institute Workshop. JAMA 1989, 262:931-934.
3. Souhami L, Gil RA, Allan SE, et al.: A randomized trial of chemotherapy followed by pelvic radiation therapy in stage IIIB carcinoma of the cervix. J Clin Oncol 1991, 9:970-977.
4. Sundfor K, Trope C, Hogberg T, et al.: Radiotherapy and neoadjuvant chemotherapy for cervical carcinoma. Cancer 1996, 77:2371-2378.
5. Leborgne F, Leborgne J, Doldan R, et al.: Induction chemotherapy and radiotherapy of advanced cancer of the cervix: a pilot study and phase III randomized trial. Int J Radiat Oncol Biol Phys 1997, 37:343-350.
6. Tattersall MHN, Lorvidhaya V, Vootiprux V, et al., for the Cervical Cancer Study Group of the Asian Oceanian Clinical Oncology Association: A randomized trial of epirubicin and cisplatin chemotherapy followed by pelvic radiation in locally advanced cervical cancer. J Clin Oncol 1995, 13:444-451.
7. Kumar L, Kaushal R, Nandy M, et al.: Chemotherapy followed by radiotherapy versus radiotherapy alone in locally advanced cervical cancer: a randomized study. Gynecol Oncol 1994, 54: 07-315.
8. Tierney J, Stewart L, Parmar M, et al.: Neoadjuvant chemotherapy for locally advancer cervical cancer: a systemic review and meta-analysis of individual patient data from 21 randomised trials. Eur J Cancer 2003, 39:2470-2486.
9. Fu KK: Biological basis for the interaction of chemotherapeutic agents and radiation therapy. Cancer 1985, 55(Suppl):2123-2130.
10. National Cancer Institute Clinical Announcement: Concurrent Chemoradiation for Cervical Cancer. Bethesda, MD: NCI; February 1999.
11. Whitney CW, Sause W, Bundy BN, et al.: Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol 1999, 17: 339-1348.
12. Rose PG, Bundy BN, Watkins EB, et al.: Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 1999, 340:1144-1153.
13. Keys HM, Bundy BN, Stehman FB, et al.: Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 1999, 340:1154-1161.
14. Morris M, Eifel PJ, Lu J, et al.: Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 1999, 340:1137-1143.
15. Peters WA, Liu PY, Barrett RJ, et al.: Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 2000, 18: 606-1613.
16. Eifel P, Winter K, Morris M, et al.: Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01. J Clin Oncol 2004, 22: 72-880.
17. Pearcey R, Brundage M, Drouin P, et al.: Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix. J Clin Oncol 2002, 20:966-972.
18. Vidaurreta J, Bermúdez A, Sardi J, et al.: Laparoscopic staging in locally advanced cervical carcinoma: a new possible philosophy? Gynecol Oncol 1999, 75:366-371.
19. Rotman M, Pajak TF, Choi K, et al.: Prophylactic extended-field irradiation of para-aortic lymph nodes in stages IIB and bulky IB and IIA cervical carcinomas: ten-year treatment results of RTOG 79-20. JAMA 1995, 274:387-393.
20. FIGO Committee on Gynecologic Oncology: Staging classifications and clinical practice guidelines of gynaecologic cancers. Int J Gynecol Obstet 2000, 70:207-312.
21. Hacker NF, Wain GV, Nicklin JL: Resection of bulky positive lymph nodes in patients with cervical carcinoma. Int J Gynecol Cancer 1995, 5:250-256.
22. Cosin JA, Fowler JM, Chen MD, et al.: Pretreatment surgical staging of patients with cervical carcinoma: the case for lymph node debulking. Cancer 1998, 82:2241-2248.
23. The Standards of Reporting Trials Group: A proposal for structured reporting of randomized controlled trials. JAMA, 1994, 272:1926-1931.
24. Green JA, Kirwan JM, Tierney JF, et al.: Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet 2001, 358:781-786.
25. Kirwan JM, Symonds P, Green J, et al.: A systematic review of acute and late toxicity of concomitant chemoradiation for cervical cancer. Radiother Oncol 2003, 68:217-226.
26. Fyles A, Milosevic M, Pintile M, et al.: Anemia, hypoxia and transfusion in patients with cervix cancer: a review. Radiother Oncol 2000, 57:13-19.
27. Obermair A, Cheuk R, Horwoods K, et al.: Anemia before and during concurrent chemoradiotherapy in patients with cervical carcinoma: effect on progression free survival. Int J Gynecol Cancer 2003, 13:633-639.
28. Grogan M, Thomas G, Melamed I: The importance of hemoglobin levels during radiotherapy for carcinoma of the cervix. Cancer 1999, 86:1528-1536.
29. Dunst J, Kuhnt T, Strauss H, et al.: Anemia in cervical cancers: impact on survival, patterns of relapse, and association with hypoxia and angiogenesis. Int J Radiat Oncology Biol Phys 2003, 56:778-787.
30. Sundorf K, Trope C, Suo Z, Bergsjo P: Normobaric oxygen treatment during radiotherapy for carcinoma of the uterine cervix: results from a prospective controlled randomized trial. Radiother Oncol 1999, 50:157-165.
31. Santin A, Bellone S, Palmieri M, et al.: Effect of blood transfusion during radiotherapy on the immune function of patients with cancer of the uterine cervix: role of interleukin-10. Int J Radiat Oncol Biol Phys 2002, 54:1345-1355.
32. Pecorelli S: The Italian gynecological consensus statement on the use of epoetin alfa in the management of anemia. Semin Oncol 2002, 29(Suppl 8):13-15.
33. Possover M, Krause N, Kuhne-Heid R, et al.: Value of laparoscopic evaluation of paraortic and pelvic lymph nodes for treatment of cervical cancer. Am J Obstet Gynecol 1998, 178:806-810.